
The U.S. Department of Justice is actively pursuing an investigation into alleged Medicare fraud involving the unauthorized use of senior citizens' ID numbers across several states to order COVID-19 tests that were neither requested nor needed.
According to a healthcare fraud prosecutor within the Justice Department, who has chosen to remain anonymous due to the ongoing nature of the investigation, there have been instances where rapid tests were billed under the names of deceased individuals. This investigation is still in its early stages, and federal authorities are only beginning to understand the full extent of the alleged fraud, which involves hundreds of thousands of tests and affects seniors and their families in at least 10 states.
A Closer Look at the Context and Challenges Faced by Providers
It is important to recognize that these allegations arise in the context of the federal government’s response to a significant public health emergency. In an effort to address the nationwide shortage of COVID-19 tests during the 2021 holiday season, the Biden administration moved quickly to expand access to free tests in early 2022. Unfortunately, the rapid deployment of this initiative may have led to unintended consequences, including the potential for misuse by third parties.
While there are claims of widespread fraud, it is crucial to approach these allegations with caution. Providers who participated in the government's efforts to distribute tests were operating under extraordinary circumstances and were responding to an urgent need to make testing available to vulnerable populations. The alleged actions of a few bad actors should not overshadow the broader context in which these providers were working.
Moreover, it is worth noting that the Centers for Medicare & Medicaid Services (CMS) has received only a small number of complaints relative to the total number of Medicare beneficiaries. The majority of providers acted in good faith and within the bounds of the law.
Advocating for Fair Investigations: Defending Providers Amid Pandemic-Related Fraud Allegations
As legal counsel for providers, we will continue to advocate for a fair and balanced investigation that considers the unprecedented challenges faced during the pandemic. It is essential that the government’s response to these allegations does not unjustly penalize those who were genuinely trying to help during a time of crisis. We remain committed to defending our clients against any unwarranted claims and ensuring that justice is served.
MORE ARTICLES BY CATEGORY
Guidance for New Entrants on Navigating PBM Audit Complexities
New pharmacy owners face complex PBM audit requirements that demand strict documentation, accurate claims, and ongoing compliance. Establishing strong recordkeeping systems and proactive audit readiness can help prevent costly recoupments and protect long-term network participation.
Read More >>How Pharmacies Can Challenge Unfair PBM Audit Findings
PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.
Read More >>Top Red Flags That May Trigger a PBM Audit
PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.
Read More >>Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week
Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.
Read More >>